With regards to TB, clearance of bedaquiline was 52% faster in Africans using a population pharmacokinetic model [211], which may be due to Africans expressing significantly more CYP3A5 compared to other populations [212]. The gene discussed is CYP3A5; the disease is tuberculosis.